A real-world study gives the edge to Eli Lilly’s weight-loss drug, Amazon faces a potential antitrust hurdle in iRobot deal, and other news to start your day.
The Fed Won’t Talk About Rate Cuts. Why Traders Are Betting on Them.
2023-11-28 19:45
A real-world study gives the edge to Eli Lilly’s weight-loss drug, Amazon faces a potential antitrust hurdle in iRobot deal, and other news to start your day.
You Might Like...
Grab 10% off Grubhub orders with this exclusive Amazon code
MrBeast: Fan favorite YouTuber follows Blackpink's Jennie on Instagram, K-pop fans say 'stay away fatty'
Volkswagen Is Testing Its Driverless Vehicles in Austin
Everything announced at WWDC that you can pre-order now
Ubisoft teases VR version of hit game 'Assassin's Creed'
Pokimane's shocking revelation about former streamer crush who called her 'cringe' leaves fans guessing who he is: 'It isn't myth'
Toyota Wants to Make More Than Just EVs — and Has Plenty of Company
Microsoft and Activision Blizzard extend merger deadline